Jan 20 () - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have struck ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Each immune cell group has distinct metabolic requirements, activation pathways, and cytokine reliance. Standard, one-size-fits-all media cannot address these features. When studying diverse cell ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.